NTRS
35
10
MSI
52
3
JWN
72
9
GE
60
5
AEP
45
5
CCL
68
6
AN
49
2
IPG
43
3
CA
19
6
MAR
57
3
BAC
38
3
EW
55
5
GS
65
16
ILMN
31
4
AKAM
50
2
HAL
40
11
VFC
56
6
VTR
44
4
TGNA
48
5
MRK
25
2
NTRS
35
10
MSI
52
3
JWN
72
9
GE
60
5
AEP
45
5
CCL
68
6
AN
49
2
IPG
43
3
CA
19
6
MAR
57
3
BAC
38
3
EW
55
5
GS
65
16
ILMN
31
4
AKAM
50
2
HAL
40
11
VFC
56
6
VTR
44
4
TGNA
48
5
MRK
25
2
Financhill
Back

Can Fite Biofarma Vs. BioLine Rx Industry Stock Comparison

Sell
16

CANF
Can Fite Biofarma

Last Price:
$1.48
Seasonality Move:
-5.63%
Sell
14

BLRX
BioLine Rx

Last Price:
$0.20
Seasonality Move:
-8.21%
Sell
16
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.48. The Score for CANF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
14
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

  • The current BioLine Rx [BLRX] share price is $0.20. The Score for BLRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

  • The BioLine Rx share price today is $0.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing selling pressure, which indicates risk of future bearish movement.

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 35.58 Sell
Chaikin Money Flow: 104053 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.51 - 2.05) Sell
Bollinger Bands (100): (1.82 - 2.58) Sell

BLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 25.22 Sell
Chaikin Money Flow: -368454 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.19 - 0.39) Sell
Bollinger Bands (100): (0.34 - 0.68) Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.5 Sell
20-day SMA: 1.73 Sell
50-day SMA: 2.07 Sell
200-day SMA: 2.37 Sell
8-day EMA: 1.5 Sell
20-day EMA: 1.67 Sell
50-day EMA: 1.93 Sell
200-day EMA: 2.32 Sell

BLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.21 Sell
20-day SMA: 0.25 Sell
50-day SMA: 0.37 Sell
200-day SMA: 0.63 Sell
8-day EMA: 0.22 Sell
20-day EMA: 0.26 Sell
50-day EMA: 0.36 Sell
200-day EMA: 0.65 Sell

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

BioLine Rx Earnings Growth & BLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and a decrease next year of $0.03 per share.

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioLine Rx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):